Cargando…

Accurate personalized survival prediction for amyotrophic lateral sclerosis patients

Amyotrophic Lateral Sclerosis (ALS) is a rapidly progressive neurodegenerative disease. Accurately predicting the survival time for ALS patients can help patients and clinicians to plan for future treatment and care. We describe the application of a machine-learned tool that incorporates clinical fe...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuan, Li-Hao, Parnianpour, Pedram, Kushol, Rafsanjany, Kumar, Neeraj, Anand, Tanushka, Kalra, Sanjay, Greiner, Russell
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10673879/
https://www.ncbi.nlm.nih.gov/pubmed/38001260
http://dx.doi.org/10.1038/s41598-023-47935-7
_version_ 1785149650882265088
author Kuan, Li-Hao
Parnianpour, Pedram
Kushol, Rafsanjany
Kumar, Neeraj
Anand, Tanushka
Kalra, Sanjay
Greiner, Russell
author_facet Kuan, Li-Hao
Parnianpour, Pedram
Kushol, Rafsanjany
Kumar, Neeraj
Anand, Tanushka
Kalra, Sanjay
Greiner, Russell
author_sort Kuan, Li-Hao
collection PubMed
description Amyotrophic Lateral Sclerosis (ALS) is a rapidly progressive neurodegenerative disease. Accurately predicting the survival time for ALS patients can help patients and clinicians to plan for future treatment and care. We describe the application of a machine-learned tool that incorporates clinical features and cortical thickness from brain magnetic resonance (MR) images to estimate the time until a composite respiratory failure event for ALS patients, and presents the prediction as individual survival distributions (ISDs). These ISDs provide the probability of survival (none of the respiratory failures) at multiple future time points, for each individual patient. Our learner considers several survival prediction models, and selects the best model to provide predictions. We evaluate our learned model using the mean absolute error margin (MAE-margin), a modified version of mean absolute error that handles data with censored outcomes. We show that our tool can provide helpful information for patients and clinicians in planning future treatment.
format Online
Article
Text
id pubmed-10673879
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-106738792023-11-24 Accurate personalized survival prediction for amyotrophic lateral sclerosis patients Kuan, Li-Hao Parnianpour, Pedram Kushol, Rafsanjany Kumar, Neeraj Anand, Tanushka Kalra, Sanjay Greiner, Russell Sci Rep Article Amyotrophic Lateral Sclerosis (ALS) is a rapidly progressive neurodegenerative disease. Accurately predicting the survival time for ALS patients can help patients and clinicians to plan for future treatment and care. We describe the application of a machine-learned tool that incorporates clinical features and cortical thickness from brain magnetic resonance (MR) images to estimate the time until a composite respiratory failure event for ALS patients, and presents the prediction as individual survival distributions (ISDs). These ISDs provide the probability of survival (none of the respiratory failures) at multiple future time points, for each individual patient. Our learner considers several survival prediction models, and selects the best model to provide predictions. We evaluate our learned model using the mean absolute error margin (MAE-margin), a modified version of mean absolute error that handles data with censored outcomes. We show that our tool can provide helpful information for patients and clinicians in planning future treatment. Nature Publishing Group UK 2023-11-24 /pmc/articles/PMC10673879/ /pubmed/38001260 http://dx.doi.org/10.1038/s41598-023-47935-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Kuan, Li-Hao
Parnianpour, Pedram
Kushol, Rafsanjany
Kumar, Neeraj
Anand, Tanushka
Kalra, Sanjay
Greiner, Russell
Accurate personalized survival prediction for amyotrophic lateral sclerosis patients
title Accurate personalized survival prediction for amyotrophic lateral sclerosis patients
title_full Accurate personalized survival prediction for amyotrophic lateral sclerosis patients
title_fullStr Accurate personalized survival prediction for amyotrophic lateral sclerosis patients
title_full_unstemmed Accurate personalized survival prediction for amyotrophic lateral sclerosis patients
title_short Accurate personalized survival prediction for amyotrophic lateral sclerosis patients
title_sort accurate personalized survival prediction for amyotrophic lateral sclerosis patients
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10673879/
https://www.ncbi.nlm.nih.gov/pubmed/38001260
http://dx.doi.org/10.1038/s41598-023-47935-7
work_keys_str_mv AT kuanlihao accuratepersonalizedsurvivalpredictionforamyotrophiclateralsclerosispatients
AT parnianpourpedram accuratepersonalizedsurvivalpredictionforamyotrophiclateralsclerosispatients
AT kusholrafsanjany accuratepersonalizedsurvivalpredictionforamyotrophiclateralsclerosispatients
AT kumarneeraj accuratepersonalizedsurvivalpredictionforamyotrophiclateralsclerosispatients
AT anandtanushka accuratepersonalizedsurvivalpredictionforamyotrophiclateralsclerosispatients
AT kalrasanjay accuratepersonalizedsurvivalpredictionforamyotrophiclateralsclerosispatients
AT greinerrussell accuratepersonalizedsurvivalpredictionforamyotrophiclateralsclerosispatients